Outcome of the Board Meeting 30052026
TTKHLTCARE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
TTK Healthcare reported audited FY2025-26 results with revenue from operations growing 7% to Rs. 85,728 lakhs from Rs. 80,149 lakhs in FY2024-25. However, profit after tax declined 19.6% to Rs. 6,568 lakhs versus Rs. 8,166 lakhs in the previous year. The decline was due to lower exceptional items - the prior year included a Rs. 1,977 lakh profit from sale of leasehold land, while the current year had a net exceptional charge of Rs. 407 lakhs (primarily Rs. 758 lakhs towards new Labour Code impact, offset partly by Rs. 350 lakh GST refund). The Board recommended a dividend of Rs. 10 per share (100%). Statutory auditors PKF Sridhar & Santhanam issued an unmodified (clean) opinion.
The PAT decline despite revenue growth reflects the absence of one-time gains seen last year; underlying operations remain stable. The clean audit and dividend recommendation are positive signals for shareholders, though the lower profitability may weigh on near-term stock performance.